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Despite constant contact with the large popula-
tion of commensal bacteria, the colonicmucosa
is normally hyporesponsive to these potentially
proinflammatory signals. Here we report that
the single immunoglobulin IL-1 receptor-
related molecule (SIGIRR), a negative regulator
for Toll-IL-1R signaling, plays a critical role in
gut homeostasis, intestinal inflammation, and
colitis-associated tumorigenesis by maintain-
ing the microbial tolerance of the colonic
epithelium. SIGIRR-deficient (Sigirr/) colonic
epithelial cells displayed commensal bacteria-
dependent homeostatic defects, as shown
by constitutive upregulation of inflammatory
genes, increased inflammatory responses to
dextran sulfate sodium (DSS) challenge, and
increased Azoxymethane (AOM)+DSS-induced
colitis-associated tumorigenesis. Gut epithe-
lium-specific expression of the SIGIRR trans-
gene in the SIGIRR-deficient background re-
duced the cell survival of the SIGIRR-deficient
colon epithelium, abrogated the hypersensitiv-
ity of the Sigirr/ mice to DSS-induced colitis,
and reduced AOM+DSS-induced tumorigene-
sis. Taken together, our results indicate that
epithelium-derived SIGIRR is critical in control-
ling the homeostasis and innate immune re-
sponses of the colon to enteric microflora.
INTRODUCTION
Up to 100 trillion commensal bacteria, which are highly di-
verse in strains, are present in the colon, providing the
host with important functions including the metabolismof nutrients and organic substrates (Sansonetti, 2004;
Hooper and Gordon, 2001; Hooper et al., 2001; Berg,
1996). The beneficial effects of the commensal bacteria
have evolved in parallel with the so-called microbial toler-
ance of the intestinal epithelial layer, in which the lack of
responsiveness to this bacterial population results in the
coexistence of the host and the bacteria. The intestinal ep-
ithelial layer functions not only as a physical barrier but
also as an innate and adaptive immune barrier against
commensal bacteria. Inappropriate activation of the
immune system by commensal bacteria is thought to
lead to the pathogenesis of human inflammatory bowel
diseases (IBD), including Crohn’s disease and ulcerative
colitis (Podolsky, 2002).
Ulcerative colitis is associated with an elevated risk for
colorectal cancer (Clevers, 2004). It is now commonly
believed that the chronic inflammation process is respon-
sible for the neoplastic transformation of the intestinal ep-
ithelium (Clevers, 2004; Balkwill and Mantovani, 2001).
The proinflammatory cytokines and chemokines, such
as TNFa, IL-1, IL-6, and IL-8, as well as matrix-degrading
enzymes, growth factors, and reactive oxygen species
(ROS), create a microenvironment that enhances cell pro-
liferation, cell survival, cell migration, and angiogenesis,
thereby promoting tumorigenesis (Coussens and Werb,
2002; Coussens et al., 2000; Dvorak, 1986). The common
view is that the association of ulcerative colitis with cancer
involves the inflammation of the submucosa, induced by
direct contact with the intestinal microflora, promoting tu-
mor outgrowth in the overlaying epithelium. Therefore, the
microbial tolerance of the intestinal epithelial layer is im-
portant not only for controlled state of inflammation but
also for preventing tumorigenesis in the colon.
This microbial tolerance of the intestinal epithelial layer
is a consequence of multiple factors involved in the inter-
action between the host and bacteria. The Toll-like recep-
tors (TLRs) is a family of pattern-recognition receptors that
detects conserved molecular patterns of microorganisms,
thereby playing a critical role in the interaction betweenImmunity 26, 461–475, April 2007 ª2007 Elsevier Inc. 461
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Role of SIGIRR in Homeostasis, Colitis, and CancerFigure 1. Increased Cell Proliferation and Survival in Sigirr/ Mice Colon
(A) Bromodeoxyuridine (BrdU, 1 mg/ml) was administrated to age- and sex-matched wild-type and SIGIRR-deficient mice by i.p. injection. 24 hr after
BrdU injection, the colon sections were stained for BrdU-positive cells (stained brown). Hemotoxylin (blue) was used as counter staining to visualize
the whole tissue. Well-oriented crypts (at least 30 crypts) were counted on slides (at least two slides) from each mouse, and 3 pairs of mice were
analyzed.
(B) Data from (A), (C), and (D) are quantified. Error bars represent ±SEM, and Student’s t test was used. *p < 0.05; **p < 0.01.462 Immunity 26, 461–475, April 2007 ª2007 Elsevier Inc.
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Role of SIGIRR in Homeostasis, Colitis, and Cancerhost and bacteria (Medzhitov et al., 1997; Rock et al.,
1998; Takeuchi et al., 1999; Chuang and Ulevitch, 2000;
Hemmi et al., 2000; Zhang et al., 2004). TLR4 (a receptor
for LPS, lipopolysaccharide), TLR2 (a receptor for LTA, lip-
oteichoic acid), and TLR9 (a receptor for CpG DNA) are
sensors for bacterial infection and are critical for the initi-
ation of inflammatory and immune defense responses.
One confounding issue with this hypothesis is that TLR li-
gands are present on both commensal bacteria and path-
ogens. As such, it remains unclear how the host remains
tolerant to commensal bacteria yet can initiate an effective
inflammatory and immune response against pathogens
when they appear. It has been shown that the spatial
and temporal expression of TLRs in the mucosal surfaces
of the intestinal tract contributes to the ability of the host to
discriminate between pathogen and resident microflora
(Melmed et al., 2003; Ortega-Cava et al., 2003). TLRs
are expressed in innate immune cells, including macro-
phages and dendritic cells (Akira et al., 2001). The lack
of pathogenic factors in commensal bacteria prevents
them from crossing the physical barrier of the gut epithe-
lium, reducing and/or excluding the contact between
commensal bacteria and innate immune cells in the gut
mucosa. However, recent studies suggest that the intesti-
nal epithelium is not totally ‘‘blind’’ to TLR ligands. Exper-
iments with TLR2-, TLR4-, and MyD88 (adaptor for TLRs)-
deficient mice suggest that TLR signaling is required for
the homeostasis of the intestinal epithelium and protects
gut epithelium from injury (Rakoff-Nahoum et al., 2004).
One of the major TLR-signaling pathways is the activation
of the IKKb-NF-kB-signaling cascade, which provides the
survival signal for epithelial cells (Greten et al., 2004; Karin
and Greten, 2005). Deletion of IKKb in the epithelial cells
reduced the colitis-associated tumor incidence in a mouse
model, indicating the direct contribution of the epithelial
cells in colitis-associated tumorigenesis (Greten et al.,
2004; Karin and Greten, 2005).
SIGIRR (also named TIR8) represents a unique sub-
group of the Toll-IL-1R superfamily, with a single immuno-
globulin extracellular domain and a TIR (Toll/IL-1R) intra-
cellular domain (Wald et al., 2003; Garlanda et al.,
2004). We previously showed that SIGIRR functions as
a negative regulator for IL-1 and LPS signaling, through
its interaction with the TLR4 and IL-1R complex (Qinet al., 2005). In this manuscript, we report that SIGIRR-de-
ficient (Sigirr/) mice exhibit dysregulated signaling in the
gut epithelium in response to commensal bacteria, which
disrupts the homeostasis of the colon epithelium and
leads to hypersusceptibility of these mice to dextran sul-
fate sodium (DSS)-induced colitis and increased colitis-
associated tumor incidence and tumor growth. The im-
portant role of SIGIRR in gut epithelium is demonstrated
by the fact that gut-epithelial-specific expression of
SIGIRR was able to restore the homeostasis of the colon
epithelium, attenuated the severity of DSS-induced coli-
tis, and reduced colitis-associated tumor incidence and
tumor growth in the Sigirr/ mice. Our results show
that SIGIRR is an important modulator of intestinal epithe-
lial homeostasis and a key regulator of mucosal immunity,
maintaining microbial tolerance of the intestinal epithelial
layer.
RESULTS
The Colon Epithelium of SIGIRR-Deficient Mice
Exhibits Altered Homeostasis
Previous studies have shown that recognition of commen-
sal bacteria by TLR2 and 4 is required for the homeostasis
of intestinal epithelium (Rakoff-Nahoum et al., 2004),
which is controlled by the balance of proliferation and dif-
ferentiation along the crypt axis. Because SIGIRR is a neg-
ative regulator for IL-1R- and TLR4-mediated pathways
and highly expressed in colonic epithelial cells (see Fig-
ure S1 in the Supplemental Data available online), we
hypothesized that Sigirr/ epithelial cells might be more
responsive to commensal bacteria in the colon. To test
this hypothesis, we examined whether the gut epithelium
in the Sigirr/ mice might suffer intrinsic homeostatic de-
fects. The proliferation state of the colon crypts of the
Sigirr/ mice was compared with the wild-type mice by
labeling the proliferating cells with BrdU administrated
by intraperitoneal injection. Colon sections were har-
vested 2 and 24 hr after BrdU injection and stained for
BrdU-positive cells (Figures 1A and 1B and data not
shown). There was an increased number of proliferating
epithelial cells in the crypts of the Sigirr/ colon as com-
pared to that in the wild-type mice. Furthermore, although
the BrdU-positive cells were only in the stem cell zone(C) DNA fragmentation in wild-type and Sigirr/ mice colon was detected by in situ TUNEL assay. Apoptotic cells were stained green and nuclei were
stained blue by DAPI. Well-oriented crypts (at least 30 crypts) were counted on slides (at least two slides) from each mouse, and 3 pairs of mice were
analyzed.
(D) Aged wild-type and Sigirr/ mice (9 months old) were sacrificed and colon was excised. After PBS wash, the colon was cut open longitudinally
and Swiss-roll was made. Sections of Swiss-roll were stained by Hematoxylin and eosin and crypt length was measured. Well-oriented crypts (at least
30 crypts) were measured on slides (at least two slides) from each mouse, and 3 pairs of mice were analyzed. Scale bar represents 100 mM.
(E–G) Colon epithelial cells from Sigirr/ mice are constitutively activated and hyperresponsive to IL-1 and LPS stimulation. Colon epithelial cells
prepared from wild-type or Sigirr/ mice were untreated or stimulated with IL-1 (10 ng/ml), LPS (10 mg/ml), or TNFa (10 ng/ml) for 15 or 30 min. Cells
were then lysed and cell lysates were resolved by SDS-PAGE. Immunoblotting was performed to detect TLR and IL-1R signaling components with
anti-phospho-NF-kB (p-p65), anti-phospho-JNK, anti-IkBa, and anti-phosphor-IkBa (E and F) or proliferation and apoptosis markers with anti-Cyclin
D1 and anti-Bcl-xL (G).
(H and I) Depletion of commensal bacteria abolished dysregulated cell proliferation in colon of Sigirr/ mice. Wild-type and Sigirr/ mice were
treated with four different antibiotics in drinking water (1 g/l ampicillin, 500 mg/l vancomycin, 1 g/l neomycin sulfate, and 1 g/l metronidazole) for 4
weeks. Bromodeoxyuridine (BrdU, 1 mg/ml) was administrated to antibiotic-treated mice via i.p. injection 24 hr prior to sacrifice. Colon sections
from 4 pairs of mice were examined for BrdU-positive cells (brown staining).Immunity 26, 461–475, April 2007 ª2007 Elsevier Inc. 463
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the proliferating epithelial cells were also found in the mid-
dle and upper regions of the crypts in the Sigirr/ colon,
where cells normally are differentiated and nonproliferat-
ing. Taken together, these results indicate that the epithe-
lial cells in the Sigirr/ colon exhibit a dysregulated state
in their basal proliferation.
To further compare the homeostasis of the colon epi-
thelium between Sigirr/ mice and wild-type mice, we
examined epithelial cell survival and apoptosis in the
crypts. In situ TUNEL assay was performed on colon sec-
tions to examine the DNA fragmentation caused by apo-
ptosis. As shown in Figure 1C, Sigirr/ colon epithelium
had fewer apoptotic cells at the top of the crypts as com-
pared to the wild-type colon, which provides further evi-
dence for imbalanced homeostasis in the Sigirr/ colon
epithelium.
To address the impact of this imbalance over an
extended period, we examined aged Sigirr/ and wild-
type mice kept under identical conditions. When 9-month-
old mice were examined, we noted a striking elongation in
Sigirr/ colon crypts, at more than twice the length of
wild-type mice. In addition, goblet cells increased in both
size and number in aged Sigirr/ mice as compared to lit-
termate wild-type control mice (Figure 1D). The elongation
of colon crypts was observed in as early as 5-month-old
Sigirr/ mice as compared to wild-type mice (data not
shown). These phenotypic changes in the Sigirr/ colon
crypts are consistent with the increased proliferation and
cell survival of the Sigirr/ epithelial cells.
Constitutive Signaling in SIGIRR-Deficient Colon
Epithelium Is Dependent on Commensal Bacteria
To investigate the molecular mechanism for the altered
homeostasis of the Sigirr/ colon epithelium, we exam-
ined signaling in these epithelial cells. Interestingly, we
found that Sigirr/ colon epithelial cells revealed consti-
tutive NF-kB, IkB, and JNK phosphorylation, indicating
constitutive NF-kB and JNK activation (Figure 1E). Upon
IL-1 or LPS (but not TNFa) stimulation, the Sigirr/ colon
epithelial cells showed even higher activation, compared
to the control cells (Figures 1E and 1F). Such constitutive
signaling and hyperactivation probably underlie the in-
creased proliferation and survival of the Sigirr/ colon
epithelial cells. Furthermore, Sigirr/ colon epithelial cells
had upregulated expression of Cyclin D1 and Bcl-xL com-
pared to that in wild-type cells. IL-1 stimulation further in-
duced the expression of Cyclin D1 in the Sigirr/ colon
epithelial cells, compared to the control cells (Figure 1G).
These results indicate that Cyclin D1 and Bcl-xL are prob-
ably part of the effector molecules responsible for the
increased cell proliferation and reduced apoptosis in the
colon epithelium of the Sigirr/ mice.
To test whether the constitutive signaling in Sigirr/ co-
lon epithelium is dependent on commensal bacteria-
derived ligands, we removed commensal bacteria from
Sigirr/ and wild-type mice through oral administered an-
tibiotics, including vancomycin, neomycin, metronidazole,
and ampicillin (VNMA). The depletion of the commensal464 Immunity 26, 461–475, April 2007 ª2007 Elsevier Inc.bacteria was confirmed by counting the bacteria in the
stool of untreated and antibiotic-treated mice (Figure S2
and data not shown). To compare the proliferation of the
epithelial cells in the Sigirr/ mice with that in wild-type
mice after the removal of commensal bacteria, we injected
BrdU into the antibiotic-treated Sigirr/ and wild-type
mice intraperitoneally. Colon sections were harvested 24
hr after BrdU injection and stained for BrdU-positive cells.
As shown in Figures 1H and 1I, the number and pattern of
BrdU-positive cells (proliferating epithelial cells) in the
crypts were similar between the antibiotic-treated
Sigirr/ colon and that in wild-type mice. These results
clearly showed that the removal of commensal bacteria
abolished that hyperproliferative state of the Sigirr/ co-
lon epithelium, indicating that the increased proliferation
of the colon epithelial cells in Sigirr/ mice (Figures 1A
and 1B) depends on the presence of commensal bacteria
in the colon. Furthermore, colonic epithelial cells from an-
tibiotic-treated Sigirr/ and wild-type mice were also ex-
amined for signaling. Similar amounts of NF-kB and JNK
phosphorylation were observed in colon epithelium cells
of the Sigirr/ and wild-type mice after the removal of
commensal bacteria, indicating that the constitutive
signaling in Sigirr/ colonic epithelial cells is indeed de-
pendent on commensal bacteria (data not shown).
The Impact of SIGIRR Deficiency
on Intestinal Inflammation
Based on these homeostatic changes, we wondered
whether the microflora-mediated constitutive activation
of Sigirr/ colon epithelium may ultimately lead to spon-
taneous colitis. Comparison of the colon sections be-
tween wild-type and Sigirr/ (2–12 months old) mice
did not reveal significant infiltration of inflammatory cells
and did not detect obvious tissue damage (data not
shown), although the crypts were dramatically elongated
in 5- to 9-month-old Sigirr/ distal colon as compared
to that in wild-type mice (Figure 1D). However, by ELISA,
we did find that the Sigirr/ colonic mucosa showed sig-
nificantly higher expression of cytokines (TNF-a, IL-6, and
IFN-g) and chemokines (MIP-2, MCP-1, and KC) as
compared to wild-type colon (Figure 2). These results
suggest that although the Sigirr/ mice do not develop
overt spontaneous colitis, the physiologic inflammation
typically found in the colonic mucosa is exaggerated
inSigirr/mice. This may make them far more susceptible
to colitis when the colon is challenged by noxious stimuli.
Sigirr/ mice has been reported to be more sensitive to
DSS-induced colitis (Garlanda et al., 2004). We also em-
ployed the DSS-induced colitis model to investigate the
mechanism by which SIGIRR regulates intestinal inflam-
mation. Both Sigirr/ and wild-type mice were continu-
ously treated with 3% DSS in drinking water. 9 days after
DSS treatment, the Sigirr/ mice began to die, and by the
end of day 13, all of the mice (n = 15) had died. In contrast,
the entire cohort of wild-type mice was still alive even at
day 16 (Figure 3A). These results clearly indicate that the
Sigirr/ mice were much more susceptible to DSS treat-
ment as compared to wild-type mice. The DSS-induced
Immunity
Role of SIGIRR in Homeostasis, Colitis, and CancerFigure 2. Constitutive Upregulation of Proinflammatory Cytokines and Chemokines in Colon of Sigirr/ Mice
Same amount of colon tissue from wild-type and Sigirr/ mice (ranging from 200 to 300 mg) was cut into small pieces and incubated in serum-free
RPMI medium for 24 hr, and secreted cytokines (IL-6, TNFa, and IFNg) and chemokines (KC, MIP-2, and MCP-1) in the medium were measured by
ELISA. Error bars represent ±SEM, and Student’s t test was conducted. *p < 0.05.colitis phenotype in Sigirr/ mice appeared to be
much stronger than that described by Garlanda et al.
(2004) for the Sigirr/ mice, which could be due to strain
difference or difference of the microflora spectrum in the
colon.
The higher mortality of the Sigirr/ mice was associated
with increased gut injury caused by DSS treatment. Histol-
ogy analysis of colon sections showed increased damage
in Sigirr/ epithelial layer as compared to that in wild-
type mice after the DSS treatment (Figure 3B and
Figure S3). By immunofluorescent staining for infiltrating
leukocytes, we found that colon sections of DSS-treated
Sigirr/ mice had highly increased numbers of infiltrated
inflammatory cells as compared to those in wild-type mice
(Figure S4). Furthermore, inflammatory cytokine gene
and protein expression were also clearly induced to much
higher amounts in DSS-treated Sigirr/ colon than the
wild-type mice, including IL-12 p40, IFN-g, IL-17, IL-6,
and IL-1b (Figure 3C and Figure S5). Taken together, the
above results indicate thatseveredamageof colonic epithe-
lium in DSS-treated Sigirr/ mice is due to increased
inflammation.
We then examined whether hypersensitivity of the
Sigirr/ mice to DSS challenge is dependent on the pres-
ence of commensal bacteria. Antibiotic-treated Sigirr/
and wild-type mice were treated with 3% DSS and fol-
lowed by histology analyses. As shown in Figure 3D and
Figure S6, antibiotic treatment reduced the sensitivity of
the Sigirr/mice to DSS treatment. The antibiotic-treated
Sigirr/ mice showed similar inflammatory response to
DSS treatment as the antibiotic-treated wild-type mice.
These results demonstrate that the regulatory role of
SIGIRR in DSS-induced colitis is commensal bacteria
dependent, probably through its negative regulation on
TLR-IL-1R-mediated-signaling induced directly or indi-
rectly by commensal bacteria.The Impact of SIGIRR Deficiency
on Colitis-Associated Cancer
We next examined the impact of SIGIRR deficiency on co-
litis-associated cancer. The link between chronic inflam-
mation and tumorigenesis has been well established for
colorectal cancer (Clevers, 2004; Balkwill and Mantovani,
2001). Because SIGIRR plays an important role in main-
taining colonic epithelial homeostasis and controlling in-
testinal inflammation, we predict that SIGIRR should
have an impact on inflammation-induced cancer in the co-
lon tissues. To test this hypothesis, we employed a mouse
model of colitis-associated cancer (CAC), injecting mice
with procarcinogen AOM (Azoxymethane) followed by
three cycles of oral administration of DSS (Okayasu
et al., 1996). Although AOM treatment introduces genetic
instability and mutation of oncogenes in epithelia, mice
developed chronic colitis after repeated treatment with
DSS, accelerating tumor promotion and progression in
colon. Sigirr/ and wild-type mice were subjected to
this AOM+DSS-induced colitis-associated cancer model.
Whereas 63% of the wild-type mice developed macro-
scopic polyps, all the Sigirr/ mice developed colon tu-
mors (Figure 4A). The tumors detected in both wild-type
and Sigirr/ mice were exclusively located in distal colon.
Some of Sigirr/ mice showed severe rectal bleeding, di-
arrhea, or loss of weight toward the end of treatment. Fur-
thermore, the average tumor number per mouse (17 ±
4.03) in Sigirr/ mice was twice more than that in wild-
type mice (7 ± 3.3) (Figure 4B). These results showed
that tumor incidence was increased in Sigirr/ mice, indi-
cating that SIGIRR deficiency enhances colitis-associated
tumor promotion. SIGIRR deficiency also had impact on
the size of the tumors. About 60% of the polyps developed
in wild-type mice were small adenomas (<2 mm diameter),
whereas the size of the other 40% polyps were 2–5 mm in
diameter (Figure 4C and Figure S7). Remarkably, aboutImmunity 26, 461–475, April 2007 ª2007 Elsevier Inc. 465
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Role of SIGIRR in Homeostasis, Colitis, and CancerFigure 3. Sigirr/ Mice Are Highly Susceptible to Develop DSS-Induced Colitis
SIGIRR-deficient and wild-type control mice were treated continuously with 3% DSS in drinking water.
(A) Kaplan-Meier plot of survival of wild-type and Sigirr/ mice (n = 15) after DSS treatment for 16 days.
(B) Hematoxylin and eosin staining of colonic cross sections of mice treated with 3% DSS for various days (original magnification 1003).
(C) Increased cytokine production in colon of Sigirr/ mice after DSS treatment. 200 mg of colon tissue was removed from Sigirr/ and wild-type
mice. Whole-colon culture was collected on various days after treatment with 3% DSS, and cytokine production was examined by ELISA. Error bars
represent ±SEM, and Student’s t test was conducted. *p < 0.05, **p < 0.01.
(D) Removal of commensal bacteria abolished the hypersensitivity of Sigirr/ colon to DSS treatment. Wild-type and Sigirr/ mice were treated with
four different antibiotics as described in Experimental Procedures for 4 weeks and followed by DSS (3%) treatment for 3–7 days. H&E staining was
conducted to examine the histology of cross-sections from Sigirr/ and WT mice. Magnification 503.70% of the polyps formed in Sigirr/ mice were big tu-
mors (>2 mm diameter), and each mouse developed one
or two large tumor (>5 mm diameter) with histology char-
acteristics of adenocarcinoma (Figures 4C and 4D). These
results indicate that SIGIRR deficiency not only enhances
tumor promotion but also increases tumor progression.
Histology analyses showed that all the tumors formed in466 Immunity 26, 461–475, April 2007 ª2007 Elsevier Inc.wild-type mice were tubular adenomas, with no sign of in-
vasion to mucosa or muscular layer (Figure 4D). However,
the large tumors formed in Sigirr/ mice showed high-
grade dysplasia, less differentiation, and obvious infiltra-
tion of inflammatory cells (Figure 4D). We frequently ob-
served crypts penetrating into the mucosa or muscular
mucosa (Figure 4D).
Immunity
Role of SIGIRR in Homeostasis, Colitis, and CancerFigure 4. SIGIRR Deficiency Enhances Tumorigenesis in Mouse Colon
(A) Tumor incidence induced by AOM plus DSS regime in Sigirr/ and WT mice. Wild-type, n = 13; Sigirr/, n = 14.
(B) Total colonic polyps formed in colorectal of Sigirr/ and WT mice.
(C) Size distribution of colonic tumors formed in Sigirr/ and WT mice. The data shown are the mean ± SD (WT, n = 13; KO, n = 14), and p < 0.0001
according to ANOVA analysis.
(D) Histology of tumors formed in Sigirr/ and WT mice. Photomicrograph of hematoxylin and eosin-stained sections of Sigirr/ and WT mice are
shown. Magnification 163 or 1003. Arrows point to crypts found in the mucosa and muscular mucosa.Hyperactivation of NF-kB and STAT3 Contribute to
Increased Tumorigenesis in SIGIRR-Deficient Mice
To examine how SIGIRR deficiency leads to increased tu-
mor promotion and progression, we first compared the
proliferation status of colon epithelium of the Sigirr/
mice with that of wild-type control mice at the early stage
of tumorigenesis upon AOM and DSS treatment. After
AOM injection and the first cycle of DSS treatment, we de-
tected increased Ki-67-positive cells in the colon epithe-
lium of Sigirr/ mice as compared to that in wild-type
control mice, indicating that cell proliferation is increased
in Sigirr/ epithelium (Figure 5A). Previous studies have
shown that NF-kB activation in colon epithelial cells has
important tumor-promoting function (Karin and Greten,
2005). The NF-kB pathway was indeed activated at a
higher amount in the colon tissue of Sigirr/ mice (with
more phosphorylation of IKK, IkB, and NF-kB) after
AOM+DSS treatment as compared to that in wild-type
control mice (Figure 5B). NF-kB nuclear accumulation
was increased in epithelium of Sigirr/ mice, confirming
the activation of NF-kB (data not shown). Consequently,
expression of NF-kB target genes Bcl-xL and Cyclin D1
(which are important for cell survival and proliferation)
was highly induced in colon tissues of Sigirr/ mice (Fig-
ures 5B and 5C). In addition to increased cell proliferation,
inflammation and damage of crypt cells were much more
evident in Sigirr/ mice at the early stage of tumorigene-
sis after the initial AOM and DSS treatment. We detectedmuch stronger induction of inflammatory gene COX2
(Figure 5B) and cytokines (IL-17, TNF-a, and IL-6) in colon
tissues of Sigirr/ mice as compared to that in wild-type
mice (Figure 5D). In particular, IL-6 has been shown to pro-
mote tumor progression in inflammation-associated can-
cer models through the activation of oncogene STAT3
(Becker et al., 2004). Consistent with this, nuclear accu-
mulation of phospho-STAT3 was indeed increased in
Sigirr/ epithelium as compared to that in wild-type
mice (Figure 5E), which probably contributed to the
increased cell proliferation observed in the Sigirr/ epi-
thelium. Taken together, the above results showed that
NF-kB and STAT3 were highly activated during the early
stage of tumorigenesis in Sigirr/ colon epithelium, which
in turn promote tumor formation through the expression of
their target genes (including Cyclin D1 and Bcl-xL) impor-
tant for cell survival and proliferation.
Human colon cancers often have mutation and/or loss
of heterozygosity in the key components of APC (adeno-
matous polyposis coli)-b-catenin pathway, indicating an
essential role for b-catenin in carcinogenesis of the colon
(Radtke and Clevers, 2005; Gregorieff and Clevers, 2005).
It has been reported that b-catenin, rather than APC, is of-
ten mutated in AOM-induced murine colon tumors (Greten
et al., 2004; Guda et al., 2004). b-catenin nuclear accumu-
lation was indeed detected by immunohistochemistry
showing a shift of b-catenin from the membrane toward
a cytoplasmic and nuclear localization in the tumor tissuesImmunity 26, 461–475, April 2007 ª2007 Elsevier Inc. 467
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Role of SIGIRR in Homeostasis, Colitis, and CancerFigure 5. Increased Cell Proliferation and Enhanced Inflammatory Response in Sigirr/ Mice during Early Stage of Tumorigenesis
Induced by AOM+DSS Treatment
(A) Increased cell proliferation of colon epithelia of Sigirr/ mice. Immunohistochemical staining was performed to examine Ki-67-positive cells on
cross-sections of colons from Sigirr/ and WT mice on day 15 under AOM plus DSS regime (magnification 1003). Ki-67-positive cells were quan-
titated from 6 cross-sections of two pairs of mice. Error bars represent ±SEM, *p < 0.05 according to Student’s t test.
(B) NF-kB pathway is highly activated in Sigirr/ mice. Protein lysates were prepared from whole colon tissue from two pairs ofSigirr/ and WT mice
on day 15 of AOM plus DSS regime. Western blotting was performed with antibodies against p-IKKa/b, p-p65, COX2, and Actin. 1# and 2# represent
samples from two individual mice.468 Immunity 26, 461–475, April 2007 ª2007 Elsevier Inc.
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ing that b-catenin pathway was activated in this tumor
model. b-catenin nuclear accumulation probably resulted
from AOM-induced mutations in components of the b-cat-
enin pathway in both wild-type and Sigirr/ mice. The
hyperactivation of NF-kB and STAT3 in Sigirr/ colon ep-
ithelium after AOM+DSS treatment are probably responsi-
ble for the increased tumor incidence and tumor growth in
Sigirr/ mice by promoting tumor formation of the trans-
formed cells (with activated b-catenin) mutated by AOM.
The Impact of Gut-Epithelial Cell-Specific
Expression of SIGIRR on the Homeostasis
of Colon Epithelium, Intestinal Inflammation,
and Tumorigenesis
One important question is what cell type is mainly respon-
sible for the regulatory role of SIGRR in gut mucosal immu-
nity. Although SIGIRR is highly expressed in colon epithe-
lial cells, substantial amounts of SIGIRR expression were
also detected in T cells (Figure S1). Therefore, it is im-
portant to determine the relative contribution of bone
marrow-derived versus non-bone marrow-derived cells
for SIGIRR’s action in the gut. Interestingly, we found
that the Sigirr/ mice that received bone marrow from
either wild-type or Sigirr/ mice died much faster than
wild-type mice transplanted with wild-type or Sigirr/
bone marrow upon DSS treatment, indicating the main
contribution of the non-bone marrow-derived tissue cells
to SIGIRR’s function in intestinal inflammation (Figure S8).
The fact that wild-type or Sigirr/ mice transplanted with
bone marrow from Sigirr/ mice had somewhat stronger
phenotype as compared to those transplanted with wild-
type bone marrow also implicated some degree of contri-
bution of bone marrow-derived cells to SIGIRR’s function
in regulating DSS-induced colitis.
To examine the function of SIGIRR in gut epithelial cells,
we generated a gut-epithelial-specific SIGIRR-transgenic
mouse by constitutively expressing SIGIRR in the distal
small intestinal and colonic epithelium. We chose toexpress
flag-tagged SIGIRR under the control of transcriptional reg-
ulatory elements derived from a fatty acid-binding protein
gene, a gut-epithelial-specific gene (Figures S9A and S9B;
Saam and Gordon, 1999). The expression of SIGIRR trans-
gene was examined by immunoprecipitation with Flag anti-
body followed by immunoblot analysis with anti-SIGIRR.
The SIGIRR transgene was specifically expressed in intes-
tine and colon but not in other tissues (Figure S9C).
To address the function of SIGIRR in gut epithelial cells,
the gut-epithelial-specific SIGIRR-transgenic mouse was
bred to SIGIRR-deficient mice to create a mouse in whichSIGIRR is expressed only in gut epithelial cells and not in
other tissues or cell types. We named this mouse SIGIRR-
TG–KO. The expression of SIGIRR transgene in the colon
of SIGIRR-TG–KO mice was comparable to that in wild-
type mice (Figure 6A). Because SIGIRR deficiency leads
to increased cell proliferation and survival in the colon
epithelium, we examined the impact of gut-epithelial ex-
pression of SIGRR transgene on homeostasis of colon ep-
ithelium. We compared cell survival and apoptosis of the
colon epithelium between SIGIRR-TG–KO and Sigirr/
mice by in situ TUNEL assay. Interestingly, we found
that more apoptotic cells were detected in SIGIRR-TG–
KO colon epithelium as compared to Sigirr/ mice (KO)
(Figure 6B), suggesting that gut-epithelial cell-specific ex-
pression of SIGIRR transgene reduced cell survival.
To examine the effect of gut-epithelial cell-specific
expression of SIGIRR on intestinal inflammation, the
SIGIRR-TG–KO mice were compared with Sigirr/ mice
for their susceptibility to DSS-induced colitis. Both
SIGIRR-TG–KO and Sigirr/ mice were continuously
treated with 3% DSS in drinking water. Although all of
the Sigirr/ mice died 14 days after DSS treatment,
only 45% of the SIGIRR-TG–KO mice died at day 16 after
DSS treatment (Figure 6C). These results clearly showed
that the SIGIRR-TG–KO mice are more resistant to DSS
treatment as compared to Sigirr/ mice.
In support of the lethality curve, histology analysis of co-
lon sections detected much reduced inflammation and
less tissue damage in epithelial layer of the SIGIRR-TG–
KO mice as compared to that in Sigirr/ mice (Figure 6D
and Figure S10). Consistent with the histology data, the in-
flammatory gene expression was induced at much lower
amounts in DSS-treated SIGIRR-TG–KO colon as com-
pared to that in Sigirr/ colon, including IL-6, TNF-a,
and IFN-g (Figure 6E). Taken together, the above results
indicate that the specific expression of SIGIRR in gut ep-
ithelial cells can rescue the Sigirr/ mice from developing
severe DSS-induced colitis.
Lastly, we examined the effect of gut-epithelial cell-
specific expression of SIGIRR on colitis-associated can-
cer. We first injected the SIGIRR-TG–KO mice with AOM
followed by three cycles of oral administration of DSS. In
comparison with Sigirr/ mice, re-expression of SIGIRR
exclusively in intestinal epithelia reduced the tumor inci-
dence to 68% (Figure 6F), which is close to that of wild-
type mice. Furthermore, the average total and big tumors
(>2 mm) per mouse was greatly reduced in SIGGIR-TG–
KO mice (Figures 6G and 6H), indicating that SIGIRR’s
expression in epithelial cells has the ability to suppress
colitis-associated tumorigenesis.(C) Immunochemical staining was performed to examine the nuclear accumulation of cyclin D1 on colonic cross-sections from Sigirr/ and WT mice
on day 15 under AOM plus DSS regime.
(D) Cytokine production in Sigirr/ and WT mice. On day 15 under the AOM plus DSS regime, 200 mg of colon tissue was removed from Sigirr/ and
wild-type mice. Whole colon cultures were subsequently prepared as described in Experimental Procedures. ELISA was conducted to measure
cytokine production. Error bars represent ±SEM, and Student’s t test was conducted. *p < 0.05.
(E) Immunohistochemical staining of p-STAT3 on colonic cross-sections of Sigirr/ and WT mice on day 15 of AOM plus DSS regime.
(F) Nuclear b-catenin staining in tumors from WT and Sigirr/ mice after the completion of the AOM plus DSS regime. Note the line separating tumor
from adjacent normal tissue. Magnification 1003 or 4003.Immunity 26, 461–475, April 2007 ª2007 Elsevier Inc. 469
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Role of SIGIRR in Homeostasis, Colitis, and CancerFigure 6. Gut-Epithelial-Specific Expression of SIGIRR Transgene Rescued the Sigirr/ Mice from Severe DSS-Induced Colitis
(A) Protein lysates were prepared from colon crypts of the Sigirr/, SIGIRR-TG–KO, and wild-type mice and followed by western analysis with anti-
SIGIRR and anti-Actin (R&D).
(B) DNA fragmentation was detected on frozen colon sections by in situ TUNEL assay. At least 30 intact crypts were counted on each slide of three
pairs of mice. The data shown is the mean ±SEM. *p < 0.05 compared to Sigirr/ mice, Student’s t test.
(C) Kaplan-Meier plot of survival study of SIGIRR-TG–KO and Sigirr/ mice under 3% DSS treatment (p < 0.0001 and n = 14).
(D) Hematoxylin and eosin staining of colonic cross-sections of untreated or DSS-treated mice (magnification 2003).
(E) Whole-colon cultures were prepared from colons of SIGIRR-TG–KO orSigirr/mice under DSS treatment for indicated days. The same segments
of colon with the weight of 250 mg were cut into small pieces and incubated with 1 ml of serum-free RPMI medium for 24 hr, and the secreted cy-
tokines and chemokines in the medium were then measured by ELISA. Data shown are the mean ± SEM from three experiments. Student’s t test was
conducted. *p < 0.05, **p < 0.01.
(F–H) Intestine-specific transgene of SIGIRR suppress colonic carcinogenesis in Sigirr/ mice. The data shown are the mean ± SD (Sigirr/, n = 13;
SIGIRR-TG–KO, n = 11), p < 0.0001 according to ANOVA analysis.470 Immunity 26, 461–475, April 2007 ª2007 Elsevier Inc.
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Role of SIGIRR in Homeostasis, Colitis, and CancerFigure 7. Chemokine Production Was Highly Induced in Sigirr/ Colon Tissue and Crypt Cells after DSS Treatment
(A and B) Chemokine production from whole-colon tissue culture (A) or protein lysate of isolated crypt cells (B) from Sigirr/ and WT mice was mea-
sured by ELISA.
(C and D) Chemokine production from whole-colon tissue culture (C) or protein lysate of isolated crypt cells (D) from Sigirr/ and SIGIRR-TG–KO
mice was measured by ELISA. 200 mg of colon tissue was used for whole-colon tissue culture or isolation of crypt cells as described in Experimental
Procedures. Error bars represent ±SEM, and Student’s t test was conducted. *p < 0.05, **p < 0.01.The Role of Epithelial-Derived SIGIRR in the
Regulation of Chemokine Gene Expression
The above results showed that epithelial-derived SIGIRR
can specifically rescue DSS-induced colitis and suppress
colitis-associated tumorigenesis. The question was then
how SIGIRR modulates intestinal inflammation and tumor-
igenesis through its function in epithelial cells in response
to intestinal microflora. Considering that the epithelium
can play an important role in attracting inflammatory and
immune cells, we examined the expression of several
chemokine genes within the inflamed colon. By RT-PCR
and ELISA, it was found that the DSS-treated and
AOM+DSS-treated Sigirr/ colon had much greater ex-
pression of chemokine genes that play critical roles in
the recruitment of T cells (IP-10 and MIG), neutrophils
(KC and MIP-2), and macrophages (Rantes and MCP-1)
as compared to that in wild-type mice (Figure 7A and
Figure S11). To address the specific role of the colonicepithelium in the DSS-induced inflammatory response,
we isolated crypt epithelial cells from wild-type and
Sigirr/ colon untreated or treated with DSS. Interest-
ingly, the Sigirr/ crypt epithelial cells produced much
higher amounts of chemokines after DSS treatment as
compared to wild-type crypt cells, including MCP-1,
MIP-2, and KC (Figure 7B). These results indicate that
much of the increased chemokine expression found in
the DSS-treated Sigirr/ mice was mediated by epithelial
cells, and the epithelial response probably plays a critical
role in DSS-induced colitis.
We then further addressed the role of epithelial-derived
SIGIRR in the regulation of chemokine gene expression by
using the SIGIRR-TG–KO mice. Interestingly, the colon
tissues from SIGIRR-TG–KO had reduced basal amounts
of chemokines and also reduced induction of chemokines
after DSS treatment as compared to Sigirr/ mice (Fig-
ure 7C). These results suggest that the expression ofImmunity 26, 461–475, April 2007 ª2007 Elsevier Inc. 471
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constitutive activation of chemokine genes and also
DSS-induced chemokine gene expression. Furthermore,
the crypt cells from DSS-treated SIGIRR-TG–KO mice
produced much lower amounts of chemokines as com-
pared to the crypt cells from DSS-treated Sigirr/ mice
(Figure 7D). These results indicate that the expression of
SIGIRR transgene in gut epithelial cells suppressed the
production of chemokines, which is likely to be the main
mechanism for how the SIGIRR transgene rescued the
Sigirr/ mice from developing severe DSS-induced coli-
tis, thereby suppressing colitis-associated cancer. Taken
together, our results clearly indicate that the impact of
SIGIRR on the intestinal inflammation and tumorigenesis
is mainly through its function in gut-epithelial cells.
DISCUSSION
The results presented here reveal an important role of
SIGIRR in regulating the interaction between commensal
microflora and colonic epithelium. The recent study by
Rakoff-Nahoum et al. suggests that activation of TLR
signaling by commensal microflora is required for the
homeostasis of the gut epithelium (Rakoff-Nahoum
et al., 2004). Mice deficient in TLR signaling have dysregu-
lated intestinal homeostasis, causing them to be more
sensitive to DSS-induced injury. The results in this manu-
script indicate that excessive commensal bacteria-
induced TLR-IL-1R-mediated signaling in the colon is
also detrimental. This suggests that there is a fine balance
of pro- and anti-inflammatory signals in the colonic epithe-
lium and that this balance critically involves SIGIRR. Dele-
tion of SIGIRR, the negative regulator of TLR-IL-1R signal-
ing, leads to exaggerated commensal bacteria-induced
TLR-IL-1R signaling disrupting the homeostatic regulation
of the proliferative and inflammatory responses of the
colonic epithelium to commensal bacteria, resulting in
enhanced colitis-associated tumorigenesis.
The fact that there were more proliferating cells in the
Sigirr/ colon crypts than in control mice indicates an
intrinsic proliferative dysregulation in SIGIRR-deficient co-
lonic epithelial cells. Importantly, dysregulated prolifera-
tion in the Sigirr/ colonic epithelial cells was no longer
detected after removal of commensal bacteria from
SIGIRR-deficient mice. These results support the hypoth-
esis that the TLR ligands (such as LPS) carried by com-
mensal bacteria are recognized by Toll-like receptors in
the colon epithelial layer, mediating the proliferation and
survival of the epithelial cells to maintain the homeostasis
of the epithelium. SIGIRR probably modulates the levels of
TLR signaling in the epithelial cells either directly through
its interaction with the Toll-like receptors that are activated
by commensal bacteria or indirectly through its impact on
pathways regulated by TLR signaling.
It has been reported that mice deficient in TLR signaling
were more sensitive to DSS-induced injury (Rakoff-
Nahoum et al., 2004). It was clearly shown that the colon
damage and associated mortality in TLR-deficient mice
after DSS treatment was not due to overt inflammatory472 Immunity 26, 461–475, April 2007 ª2007 Elsevier Inc.cell infiltration. However, our results showed that inflam-
mation was the primary cause for the increased tissue
damage and high mortality in Sigirr/ mice after DSS
treatment. Importantly, gut-epithelial-specific expression
of SIGIRR transgene rescued the Sigirr/ mice from
developing severe DSS-induced colitis, indicating that
epithelial-derived SIGIRR has a major impact on intestinal
inflammation.
Previous studies showed that chronic inflammation and
cancer are closely associated in the intestine (Clevers,
2004; Balkwill and Mantovani, 2001). Indeed, we found
that Sigirr/ mice were much more susceptible to de-
velop colitis-associated cancer induced by carcinogen
AOM plus DSS as compared with wild-type mice, indicat-
ing that the Sigirr/ mice are an excellent model to study
the link between inflammation and tumorigenesis. Tumor-
igenesis can be divided into three mechanistic stages: ini-
tiation (genomic alteration), promotion (proliferation of ge-
netically altered cells), and progression (tumor growth)
(Karin and Greten, 2005). Inflammatory cells and the in-
nate immune system are shown to be important mediators
of tumor promotion and progression, but not for tumor ini-
tiation. In our colitis-associated cancer model, carcinogen
AOM introduces genomic instability and mutation of onco-
genes in the epithelia, whereas repeated DSS treatment
creates a microenvironment of chronic inflammation in
the colon. Mutations in the APC or b-catenin gene that
lead to stabilization and nuclear accumulation of b-catenin
and transcriptional activation with TCF-4 play a critical
role in the initiation of colorectal tumorigenesis. The
activation of b-catenin pathway (b-catenin nuclear accu-
mulation) was detected in the tumor tissues from both
wild-type and Sigirr/ mice, implying that AOM probably
introduced mutations to the key components of the
b-catenin pathway in these mice. When the Sigirr/
mice were subjected to AOM injection or repeated DSS
treatment alone, colon tumors were not developed (data
not shown), indicating that both AOM-induced tumor initi-
ation and DSS-induced chronic inflammation are neces-
sary for this tumor model.
NF-kB links inflammation and immunity to cancer devel-
opment and progression (Karin and Greten, 2005). As dis-
cussed above, the constitutive activation of TLR signaling
(activation of NF-kB and JNK) in the Sigirr/ epithelial
cells led to upregulation of genes for cell survival and pro-
liferation (Cyclin D1 and Bcl-xL), resulting in increased cell
survival and cell proliferation. Enterocyte-specific ablation
of IKKb was shown to decrease tumor incidence mark-
edly, indicating that IKKb-dependent NF-kB-activation in
intestinal epithelial cells operates during early tumor pro-
motion (Greten et al., 2004). Therefore, the constitutive
NF-kB activation in Sigirr/ colon epithelium is likely
to contribute to the increased tumor incidence in the
Sigirr/ mice.
In addition to increased NF-kB activation, we also de-
tected hyperactivation of STAT3 in colon epithelium of
Sigirr/ mice upon AOM+DSS treatment. IL-6, which
has been shown to promote cancer growth in inflamma-
tion-associated cancer models, was highly induced in
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production is probably responsible for the increased nu-
clear phospho-STAT3 detected in Sigirr/ epithelium.
Hyperactivation of STAT3 has been shown to promote tu-
mor progression in gastric and colonic cancers (Becker
et al., 2004). Colorectal tumors result from accumulation
of multiple changes that lead to activation of oncogenes
combined with the inactivation of tumor suppressor genes
(Radtke and Clevers, 2005). Although deletion of SIGIRR
probably does not directly introduce mutations to the co-
lon epithelium, it does lead to the activation of two impor-
tant transcription factors, NF-kB and STAT3, during the
early stage of colitis-associated tumorigenesis, which in
turn promotes cell proliferation and cell survival through
the upregulation of their target genes (including Cyclin
D1 and Bcl-xL) in Sigirr/ epithelium, leading to tumor
promotion and progression.
Our studies also implicate that SIGIRR-regulated che-
mokine gene expression plays a critical role for epithelial-
derived SIGIRR to modulate intestinal inflammation and
colitis-associated cancer. Importantly, epithelial-specific
expression of SIGIRR transgene reduced the expression
levels of chemokines before or after DSS stimulation, con-
firming the critical role of epithelial-derived SIGIRR in
the regulation of chemokine gene expression. We hypoth-
esize that the DSS-induced chemokines produced by the
Sigirr/ epithelial cells play critical roles in the recruit-
ment of the inflammatory cells to the colon mucosa, lead-
ing to severe inflammation, which in turn promotes tumor-
igenesis in the AOM+DSS model. Although our studies
demonstrate a critical role for SIGIRR expression by the
colonic epithelium, it is also clear that we can not rule
out modest regulatory roles of SIGIRR in other cell types.
In addition to its high-expression colon epithelial cells,
SIGIRR is also expressed in T cells and has low level of
expression in dendritic cells. Future experiments are
required to dissect the specific function of SIGIRR in each
cell type.
Despite the density of commensal bacteria and their
products, the colonic mucosa maintains a controlled state
of inflammation (physiologic inflammation). What is the
role of SIGIRR in the microbial tolerance of the colonic
epithelial layer? Based on the findings in this manuscript,
we propose that in addition to its function as a physical
barrier, the colon epithelial layer also functions as an ac-
tive innate immune barrier. SIGIRR is an important modu-
lator to regulate the interaction between commensal
bacteria and gut epithelium to maintain the innate immune
tolerance of the colon epithelial layer. SIGIRR plays
a critical role in preventing overreaction of the colon epi-
thelial layer to commensal bacteria, contributing to the
microbial tolerance of the colon. While loss of SIGIRR
was insufficient on its own to cause spontaneous colitis
in these mice, our findings suggest that SIGIRR is a strong
candidate for regulating inflammatory responses against
real or perceived luminal threats, with its dysregulation
possibly a predisposition to exaggerated or even chronic
forms of infectious, idiopathic colitis or colitis-associated
cancer.EXPERIMENTAL PROCEDURES
Construction of SIGIRR-Transgenic Mouse
To generate the Fabpl4x at –132/Sigirr construct, DNA encoding SIGIRR
was placed under the control of transcriptional regulatory elements
derived from a fatty acid-binding protein gene (Saam and Gordon,
1999) followed by the human growth hormone reporter gene (hGH).
Fabpl4x at 132 include elements consist of nucleotides –596 to +21
of rat Fabpl with 4 additional copies of a 35 bp sequence (spanning
nucleotides –177 to –133, that has been inserted at nucleotide –132).
Earlier light and EM immunohistochemical studies of transgenic mice
demonstrated that Fabpl4x at 132 can direct the expression of a human
growth hormone (hGH) reporter throughout the epithelium of crypts
in the distal small intestine, cecum, and colon of adult mice (Saam
and Gordon, 1999). A Flag tag was included at the N terminus of
SIGIRR to distinguish the transgene from the endogenous gene.
Fabpl4x at 132/Sigirr was sent to the Transgenic Mouse Service in
the University of Cincinnati and injected into the pronucleus of the
fertilized eggs, followed by implantation into the oviduct of a 0.5 day
p.c. pseudopregnant female mouse. The founders that carry the Sigirr
transgene were identified by genomic Southern analysis with hGH
reporter cDNA and Sigirr cDNA as probes. The Sigirr transgenic
founder lines were bred to generate F1. Sigirr transgenic mice were
bred to Sigirr/ mice to generate mice express SIGIRR only in gut-
epithelial cells. SIGIRR-TG–KO mice were maintained on C57BL/
63129/SvJ background. All of the mice utilized in this manuscript
were housed in animal facility (with SPF condition) at the Cleveland
Clinic Foundation in compliance with the guidelines set by Institutional
Animal Care and Use Committee.
DSS-Induced Colitis
Experimental colitis was induced by giving 3% (w/v) DSS (M.W.
40,000 kDa; MP Biomedicals Inc., Solon, OH) in drinking water
ad libitum. Mice (6–8 weeks) were treated for 16 days for survival
studies. For histological, gene expression, and cytokine production
studies, mice were sacrificed after DSS treatment for indicated days.
TUNEL Assay
Frozen sections obtained from untreated mice were fixed with 4% par-
aformadehyde and permeabilized by 0.1% Triton X-100. TUNEL assay
kit (Roche) was used to detect apoptotic cells and DAPI was used to
stain the nuclei.
BrdU Staining
1 mg/ml of BrdU in PBS was injected to mice via i.p. Mice were sacri-
ficed in 24 hr after BrdU injection. The same segment of distal colon
was fixed in 10% neutral formalin and paraffin embedded. Proliferating
cells were detected with BrdU detection kit (BD Bioscience). Tissues
were counterstained with hematoxylin. The number of BrdU-positive
cells was quantified by number of cells in intact, well-orientated crypts.
Whole-Colon Culture
200–300 mg of colon tissue was washed in cold PBS supplemented
with penicillin and streptomycin. These segments were cut into small
pieces and cultured in 12-well flat bottom culture plates (Falcon) in se-
rum-free RPMI medium. High concentration of penicillin and strepto-
mycin was supplemented to prevent bacteria growth. After incubation
at 37C for 24 hr, medium was collected and stored at80C until use.
Colon Crypt Isolation and Treatment
Mice colon was washed with cold PBS and cut longitudinally. After
incubation with 0.04% sodium hypochlorite (Sigma) for 30 min, colon
was cut into small pieces and shaken continuously in PBS buffer with
1 mM EGTA and 1 mM EDTA at room temperature for 30 min. Crypts
in the supernatant were collected. Collected crypt cells were lysed di-
rectly (for ELISA) or after treatment with 10 ng/ml IL-1 (National Cancer
Institute), 10 mg/ml LPS (Sigma), or 10 ng/ml TNFa (R&D System) (for
western blotting).Immunity 26, 461–475, April 2007 ª2007 Elsevier Inc. 473
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Whole-colon culture or crypt lysate from DSS-treated mice was exam-
ined for cytokine and chemokine production with ELISA kits obtained
from R&D Systems, according to the manufacturer’s instruction. Cyto-
kine and chemokine production is normalized by total colon tissue
weight (whole-colon culture) or total protein amount (crypt protein
lysate) measured by BCA analysis (Pierce). 3–4 pairs of mice were
used for each time point.
Western Blot
Crypt protein lysates were resolved by SDS-PAGE and transferred to
PVDF membrane. Blots were probed with phospho-IkBa, phospho-
p65, phospho-JNK (Cell Signaling), anti-IkBa, Cyclin-D1, Bcl-xL, and
b-Actin (Santa Cruz Biotechnology, CA). After incubation with HRP-
conjugated secondary antibody, ECL (Amersham, Arlington Heights,
IL) was used to develop.
Commensal Depletion
6- to 8-week-old mice were treated with ampicillin (A, 1 g/l, Sigma),
vancomycine (V, 500 mg/l), neomycin sulfate (N, 1 g/l), and metronida-
zole (M, 1g/l) in drinking water for 4 weeks. Stool collected from anti-
biotic-treated and untreated mice was diluted and ground in 1.5 ml
PBS. The ground stool was diluted 10 times with PBS and fixed with
formalin. 2 ml of fixed bacteria was diluted in 1 ml PBS. This dilution
was filtered through 0.2 mm Whatman Anodisc 25 filter (VWR) with
the help of low vacuum. Attached bacteria were incubated in 100 ml
of SYBR green solution (SYBR Green 1 nucleic acid gel stain, Invitro-
gen). The stained filters were dried and covered with mounting medium
on a slide. Bacteria stained on the filter were counted under fluores-
cence microscope. After commensal depletion, mice were then either
sacrificed for BrdU staining or treated with 3% DSS in drinking water
for indicated days and then sacrificed for histological study.
Tumorigenesis Procedure
8-week-old mice (Sigirr/ and WT littermates on C57BL/6 back-
ground and Sigirr/ mice and SIGIRR-TG–KO littermates on mixed
C57BL/63129/SvJ background) were injected with AOM (Sigma) dis-
solved in 0.9% NaCl intraperitoneally at a dose of 12.5 mg/kg body
weight. 5 days after injection, mice were treated with 2.5% DSS in
drinking water, then followed by regular water for 16 days. This cycle
was repeated twice (at the third cycle, mice were treated with 2.0%
DSS for 4 days) (Greten et al., 2004). 2 weeks after DSS treatment,
mice were sacrificed and murine colon was removed and flushed care-
fully with PBS buffer. Colon was then cut longitudinally and fixed flat in
10% neutral buffered formalin overnight. All of the colon tumors were
counted and measured under a stereomicroscope. Representative
tumors were paraffin embedded and sectioned at 5 mm. Histology
analysis was carried out on H&E-stained tumor sections.
Immunohistochemistry
Formalin-fixed and paraffin-embedded colon sections or tumor sam-
ples were deparaffined, rehydrated, and pretreated with 3% hydrogen
peroxidase in PBS buffer for 20 minutes. Antigen retrieval in DAKO’s
antigen retrieval buffer was conducted in a steam cooker for 20 min-
utes at 96C, followed by slowly cooling down at room temperature.
After blocking with DAKO’s block buffer, avidin/biotin block, sections
were incubated with anti-Ki67 (1:150, Dako, USA), anti-b-Catenin
(1:1000, BD Pharmingen), anti-CyclinD1 (1:50, Santa Cruz), anti-p65
(1:1000, Abcam), or anti-p-STAT3 (1:50, Abcam) for 1 hr at room tem-
perature. After incubation with biotin-conjugated secondary antibody
and streptavidin-HRP, positive signals were visualized by DAB kit
(BD pharmingen) and counterstained with Harris hematoxylin (Fisher
Scientific).
Statistic Analysis
Kaplan-Meier study was performed for analyzing mouse survival under
DSS treatment. ANOVA was used to characterize the tumorigenic474 Immunity 26, 461–475, April 2007 ª2007 Elsevier Inc.studies under AOM plus DSS regime. Student’s t test was used for
all other studies and p < 0.05 is considered significant.
Supplemental Data
Supplemental Data include 11 figures and Experimental Procedures
and can be found with this article online at http://www.immunity.com/
cgi/content/full/26/4/461/DC1/.
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